Antagomir- 17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Laura Fontana, Micol E. Fiori, Sonia Albini et al. · 2008
Read Antagomir- 17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM by Laura Fontana, Micol E. Fiori, Sonia Albini et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002236.txt.
Description
Laura Fontana, Micol Fiori, Sonia Albini, and co-authors blocked a small RNA to fight stubborn neuroblastoma, in a 2008 PLOS ONE paper. Neuroblastoma is a childhood cancer of nerve tissue, and some tumors resist therapy. The team had traced a key pathway: the cancer gene MYCN, when overactive, switches on a cluster of microRNAs that includes miR-17-5p.
Those microRNAs suppress two protective proteins, p21 and BIM, letting tumor cells grow unchecked. Blocking miR-17-5p with an antagomir, a molecule built to silence it, abolished the growth of therapy-resistant neuroblastoma in their tests. The result nominates one small RNA as a drug target in a hard cancer.
Catalog record
| CREATOR | Laura Fontana, Micol E. Fiori, Sonia Albini et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002236